Ruplizumab Antibody
Ruplizumab (BG 9588) is a humanized monoclonal antibody targeting CD40L. It is utilized in research to investigate immune modulation, with applications in studying autoimmune disorders, transplant rejection, and neuroinflammation in both in vitro and in vivo experimental models.
Product Specifications
Product Name Alternative
Anti-Human CD40L Recombinant Antibody, BG9588, BG 9588, TNF Receptor
Target
TNF
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Cell Biology
Concentration
5.47 mg/mL
Purity
95.00% (May vary between batches)
Molecular Weight
145.42 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog